Recovery With Virtual Reality for Stress and Pain (ReVRS)
Recovery With Virtual Reality for Stress & Pain (ReVRS)
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
Gedetailleerde beschrijving
Preoperative anxiety and postoperative pain may negatively affect patients' recovery after surgery. Virtual reality may provide a non-pharmacological method of distraction and relaxation, but its effect on perioperative anxiety and early postoperative recovery requires further evaluation.
This prospective, randomized, parallel-group controlled trial will include approximately 140 adults undergoing elective gynecological surgery. After providing informed consent, participants will be randomized in a 1:1 ratio to one of two groups:
- Virtual reality plus usual perioperative care.
- Usual perioperative care alone.
Participants assigned to the intervention group will use a virtual reality headset for approximately 10-20 minutes before surgery and view an immersive relaxation environment. The intervention may be discontinued at any time if the participant experiences discomfort, nausea, dizziness, anxiety, or other adverse symptoms.
The primary outcome is the change in preoperative anxiety from immediately before to immediately after the intervention period, assessed using the State-Trait Anxiety Inventory-State scale and/or a numerical rating scale for anxiety.
Secondary outcomes include quality of recovery measured with the Quality of Recovery-15 questionnaire, postoperative pain measured using a numerical rating scale, opioid consumption expressed as morphine milligram equivalents, postoperative nausea and vomiting, time spent in the postoperative care unit, and other indicators of early postoperative recovery. Follow-up assessments are planned at approximately 24 and 72 hours and on postoperative days 7 and 10.
The study will examine whether preoperative virtual reality reduces anxiety and whether any reduction is associated with improved postoperative recovery and reduced symptom burden.
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Fase
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
Studiecontact
- Naam: Pether Jildenstål, Professor
- Telefoonnummer: +46 76-026 66 58
- E-mail: pether.jildenstal@med.lu.se
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Adults aged 18 years or older.
- Scheduled to undergo elective gynecological surgery according to the study protocol at a participating center where virtual reality can be provided.
- Able and willing to provide informed consent for study participation, 1:1 randomization, and use of virtual reality.
Exclusion Criteria:
- Increased risk of adverse effects related to virtual reality, including pronounced motion sickness, claustrophobia, or photosensitive epilepsy.
- Active substance use disorder or active misuse of alcohol or illicit drugs.
- Severe chronic pain and/or regular preoperative opioid treatment, as defined in the study protocol.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Aantal wapens
Wapens en interventies
Deelnemersgroep / ArmDeelnemersgroep / Arm |
Interventie / BehandelingInterventie / Behandeling |
|---|---|
|
Experimenteel: Virtual Reality Plus Usual Care
Participants receive a preoperative virtual reality session in addition to usual perioperative care.
The session lasts approximately 10-20 minutes and is delivered in the waiting or preoperative area using calm nature or relaxation scenes intended to promote comfort and distraction.
|
A single preoperative virtual reality session lasting approximately 10-20 minutes, administered in the waiting or preoperative area.
Participants view calm nature, relaxation, or guided-breathing scenes using a virtual reality headset.
The intervention is intended to provide relaxation, comfort, and distraction before surgery.
|
|
Actieve vergelijker: Usual Care
Participants receive usual perioperative care without virtual reality during the corresponding preoperative period.
|
Participants receive standard perioperative care according to local clinical routines.
No preoperative virtual reality session is provided during the corresponding intervention period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Quality of Postoperative Recovery Measured With QoR-15
Tijdsspanne: 24 hours after surgery
|
Postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
24 hours after surgery
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Preoperative Anxiety
Tijdsspanne: From immediately before to immediately after the intervention, approximately 10-20 minutes
|
Anxiety will be assessed before and after the preoperative intervention period using the anxiety measure specified in the study protocol.
Higher scores indicate greater anxiety.
|
From immediately before to immediately after the intervention, approximately 10-20 minutes
|
|
Postoperative Pain Intensity
Tijdsspanne: Up to 72 hours after surgery
|
Postoperative pain will be assessed using a numerical rating scale from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Up to 72 hours after surgery
|
|
Postoperative Opioid Consumption
Tijdsspanne: During the first 24 hours after surgery
|
Total postoperative opioid consumption will be calculated and converted to intravenous morphine milligram equivalents.
|
During the first 24 hours after surgery
|
|
Incidence of Postoperative Nausea and Vomiting
Tijdsspanne: During the first 24 hours after surgery
|
Number and proportion of participants experiencing nausea, vomiting, or both during the postoperative period.
|
During the first 24 hours after surgery
|
|
Duration of Stay in the Post-Anesthesia Care Unit
Tijdsspanne: On the day of surgery
|
Time from admission to discharge from the post-anesthesia care unit.
|
On the day of surgery
|
|
Quality of Recovery at 72 Hours Measured With QoR-15
Tijdsspanne: 72 hours after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
72 hours after surgery
|
|
Quality of Recovery on Postoperative Day 7 Measured With QoR-15
Tijdsspanne: 7 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
7 days after surgery
|
|
Quality of Recovery on Postoperative Day 10 Measured With QoR-15
Tijdsspanne: 10 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
10 days after surgery
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
Andere studie-ID-nummers
- 2026-03077-01 (Andere identificatie: Swedish Ethical Review Authority)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .